The compound hasn't been subjected into the demanding medical screening expected for approval by regulatory bodies such as the FDA, meaning its basic safety and usefulness in treating healthcare circumstances continue to be unproven.In summary, the continued exploration of conolidine offers an remarkable frontier in pain administration, with consid